Literature DB >> 590316

Pharmacokinetics of phenobarbital in childhood.

G Heimann, E Gladtke.   

Abstract

In 14 neonates 1-4 weeks old, 30 babies aged 1-12 months, and 7 infants of 1-5 years of age, the serum levels of phenobarbital were determined by a gas chromatographic micro-method after intravenous injection of phenobarbital 5-10 mg per kg body weight. It was possible to calculate the pharmacokinetic parameters using a two compartment open model. The distribution volumes within the individual age groups and the rate constants k12 and k21 showed no significant differences, but the elimination half-life was significantly longer in neonates (118.6+/-16.1h) than in babies (62.9+/-5.2h) or infants (68.5+/-3.2h).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590316     DOI: 10.1007/bf00607431

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Placental transfer of phenobarbitone in epileptic women, and elimination in newborns.

Authors:  J C Melchior; O Svensmark; D Trolle
Journal:  Lancet       Date:  1967-10-21       Impact factor: 79.321

2.  ACCUMULATION OF PHENOBARBITAL IN MAN.

Authors:  O SVENSMARK; F BUCHTHAL
Journal:  Epilepsia       Date:  1963-12       Impact factor: 5.864

3.  Changes in body water compartments during growth.

Authors:  B FRIIS-HANSEN
Journal:  Acta Paediatr Suppl       Date:  1957-01

4.  [Intravital & postmortem reduction of barbitals].

Authors:  G SCHMIDT
Journal:  Arch Toxikol       Date:  1958

5.  Metabolic oxidation of phenobarbital to p-hydroxyphenobarbital.

Authors:  T C BUTLER
Journal:  Science       Date:  1954-09-24       Impact factor: 47.728

6.  [Intravenous load by pheno-and hexobarbital in mature and premature newborn infants and young infants].

Authors:  W Ihle; W Eggert; E L Grauel; L Weh; I Syllm-Rapoport
Journal:  Padiatr Grenzgeb       Date:  1974

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.

Authors:  J G Wagner; J I Northam
Journal:  J Pharm Sci       Date:  1967-04       Impact factor: 3.534

9.  Plasma concentrations of phenobarbital in the treatment of seizures in newborns.

Authors:  B Jalling
Journal:  Acta Paediatr Scand       Date:  1975-05

10.  Pharmocokinetics of hexobarbital in man after intravenous infusion.

Authors:  D D Breimer; C Honhoff; W Zilly; E Richter; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1975-02
View more
  15 in total

Review 1.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

2.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 3.  Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.

Authors:  Janthima Methaneethorn; Nattawut Leelakanok
Journal:  Eur J Clin Pharmacol       Date:  2020-10-19       Impact factor: 2.953

Review 4.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

Review 5.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

Review 6.  Rational usage of therapeutic drug monitoring in antiepileptic treatment.

Authors:  H Bartels
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

7.  Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia.

Authors:  Renée A Shellhaas; Chee M Ng; Christina H Dillon; John D E Barks; Varsha Bhatt-Mehta
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

8.  Determination of phenobarbitone population clearance values for South African children.

Authors:  J H Botha; A L Gray; R Miller
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 9.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.

Authors:  Gilbert O Kokwaro; Bernhards R Ogutu; Simon N Muchohi; Godfrey O Otieno; Charles R J C Newton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.